# FDA Warning Letter: Missouri Analytical Laboratories Inc
> 2021-10-12 · Division of Pharmaceutical Quality Operations III · `b245a8c470dde2d0`
## Letter
- **Company:** Missouri Analytical Laboratories Inc
- **Posted Date:** 2021-10-12
- **Letter Issue Date:** 2021-09-30
- **Issuing Office:** Division of Pharmaceutical Quality Operations III
## Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*